Cyclophosphamide altered the myocardial marker enzymes: Protection provoked by Hesperidin in Rats

International Journal of Phytomedicine

Volumn 5, Issue 2, 2013, Pages 141-145

  Shrivastava, Meenu ^a   Kar, Vasundra ^b   Shrivastava, Shobhit ^a  

^a Bansal College of Pharmacy   (India)

^b IEC College of Engineering and Technology   (India)

Author keywords

Antioxidants; Cardiotoxicity; Cyclophosphamide; Hesperidin; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CYCLOPHOSPHAMIDE; HESPERIDIN; LACTATE DEHYDROGENASE; LIPID PEROXIDE; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DRUG EFFICACY; HEART MUSCLE INJURY; HEART PROTECTION; MALE; NONHUMAN; RAT;

EID: 84888806341     PISSN: None     EISSN: 09750185     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hirano A, Shimizu T, Watanabe O, Kinoshita J, Kimura K, Kamimura M, Domoto K, Aiba M, Ogawa K. Epirubicin and cyclophosphamide followed by docetaxel as primary systemic chemotherapy in locally advanced breast cancer. Anticancer Res. 2008, 28(6B): 4137-42.
2. Zhang Jing, Tian Quan, Zhou Shu-Feng. Clinical Pharmacology of Cyclophosphamide and Ifosfamide. Current Drug Therapy. 2006, 1: 55-84(30).
3. Abraham P, Sugumar E. Increased glutathione levels and activity of PON1 (phenyl acetate esterase) in the liver of rats after a single dose of cyclophosphamide a defense mechanism. Exp Toxicol Pathol. 2008, 59(5): 301-6.
4. Amy T, Jennifer Wo, Caron J, Aaron Weitzman, Tamara Horwich, Charles Hesdorffer, David Savage, Andrea Troxel. Cardiac toxicity observed in association with high dose Cyclophosphamide-based chemotherapy for metastatic breast cancer. The Breast. 2004, 13: 341-346.
5. Lindley CMG, Hamilton J S, McCune S, Faucette S S, Shord R L, Hawke H, Wang Gilbert D S, Jolley B Yan and Lecluyse E L. The effect of Cyclophosphamide with and without dexamethasone on cytochrome p450 3A4 and 2B6 in human hepatocytes. Drug Metabolism and Disposition. 2002, 30: 814-822.
6. Murgo AJ, Weinberger BB. Pharmacological bone marrow purging in autologous transplantation: focus on the cyclophosphamide derivatives. Crit Rev Oncol Hematol. 1993, 14(1): 41-60.
7. Kern Julie C, Kehrer James P. Acroleininduced cell death: a caspase-influenced decision between apoptosis and oncosis/necrosis. Chemico-biological interactions. 2002, 139: 79-95.
8. Annida Balakrishnan, Venugopal P, Menon. Effect of hesperidin on matrix metalloproteinases and antioxidant status nicotine-induced toxicity. Toxicology. 2007, 238: 90-98.
9. Broad J, Sirota, J H. Renal clearance of endogenous creatinine in man. J. Clin Invest. 1948, 27: 646.
10. Mythili, Y, Sudharsan, PT, Selvakumar, E., Varalakshmi, P., Protective effect of DL-alpha-lipoic acid on cyclophosphamide induced oxidative cardiac injury. Chem Biol Interact. 2004, 151(1): 13-9.
11. Ahmadi A, Hosseinimehr SJ. Naghshvar F, Hajir E, Ghahremani M. Chemoprotective effects of hesperidin against genotoxicity induced by cyclophosphamide in mice bone marrow cells. Arch Pharm Res. 2008, 31(6): 794-7.
12. Lushnikova EL, Tolstikova TG, Nepomnyashchikh L M, Klinnikova M G, Molodykh O P, Sviridov E A, Sorokina I V, and Zhukova N A. Cardiomyocyte count in rat myocardium under the effect of antitumor agents cyclophosphamide and triterpenoids. Bulletin of Experimental Biology and Medicine. 2007, 144: 3.
13. Van Vleet, JF, and Ferrans, V J. Myocardial diseases of animals. American Journal of Pathology. 1986, Chopra 124: 98-178.
14. Patel JM, Block ER. Cyclophosphamideinduced depression of the antioxidant defense mechanisms of the lung. Exp Lung Res. 1985, 8(2-3): 153-65.
15. Willis ED. Effects of lipid peroxidation on membrane-bound enzymes of the Endoplasmic reticulum. Biochem J. 1971, 123: 983-991.
16. Gaganjit Kaur, Naveen Tirkey, Kanwaljit Chopra. Beneficial effect of hesperidin on lipopolysaccharide-induced hepatotoxicity. Toxicology. 2006, 226: 152-160.
17. Elangovan Selvakumar, Chidambaram Prahalathan, Periyasamy Thandavan Sudharshan, Palaninathan Varalakshmi. Protective effect of lipoic acid on Cyclophosphamide induced testicular toxicity. Clinica Chimica Acta. 2006, 367: 114-119.
18. Wilmsen P K, Spada D S, Salvador M. Antioxidant activity of the flavonoid hesperidin in chemical and biological systems. J Agric Food Chem. 2005, 53(12): 4757-61.
19. John MP, Frederick RA, Janet F E, Joseph R, Darrell R F, Ted G, Katherine R, Eneida N, Eileen S, Larry D, Jeanette C, Mary M H, Oliver W P, Ajay K G, Paul J M, Irwin D B and Dana C Matthews. 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission. Blood. 2005, 107(5): 2184-2191.
20. Kannampalli Pradeep, Sang Hyun Park, Kyong Cheol Ko. Hesperidin a flavanoglycone protects against gammairradiation induced hepatocellular damage and oxidative stress in Sprague-Dawley rats. European journal of pharmacology. 2008, 587: 273-280.
21. King J. The dehydrogenase or oxidoreductase-lactate dehydrogenase. In: Practical clinical enzymology Van D (ED). Nostrand Company Limited, London, 1965a, 83-93.
22. Kirsten J M, Schimmel Dick J, Richel, Renee B A, Van den Brink, Henk-Jan Guchelaar. Cardiotoxicity of cytotoxic drugs. Cancer treatment reviews. 2004, 30: 181-191.
23. Gharib MI, Burnett AK. Chemotherapyinduced cardiotoxicity: current practice and prospects of prophylaxis. European Journal of Heart Failure. 2002, 4: 235-242.
24. Naveen Tirkey, Sangeeta Pilkhwal, Anurag Kuhad and Kanwaljit Chopra. Hesperidin, a citrus bioflavinoid, decreases the oxidative stress produced by carbon tetrachloride in rat liver and klidney. BMC Pharmacology. 2005, 5: 2.
25. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979, 95: 351-358.
26. Grafstrom R C, Dypbukt J M, Willey J C, Sundqvist K, Edman C, Atzori L, and Harris C C. Pathobiological effects of acrolein in cultured human bronchial epithelial cells. Cancer Res. 1988, 48: 1717-1721.
27. Reitman S, Frankel S. A. colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957, 28: 56-63.
28. Serra H, Mendes T, Bronze M R, Simplício A L. Prediction of intestinal absorption and metabolism of pharmacologically active flavones and flavanones. Bioorg Med Chem. 2008, 16(7): 4009-18.
29. Subramanian Senthlikumar, Thiruvengadam Devaki, Bhakthavatchalam Murali Manohar, Munismay Suresh Babu. Effect of squalene on Cyclophosphamide induced toxicity. Clinica Chimica Acta. 2005, 364: 335-342.
30. Sudharsan, Periyasamy Thandavan, Mythili, Yenjerla, Selvakumar, Elangovan, Varalakshmi, Palaninathan. Lupeol and Its Ester Exhibit Protective Role against Cyclophosphamide-Induced Cardiac Mitochondrial Toxicity. Journal of Cardiovascular Pharmacology. 2006, 47(2): 205-210.
31. Un Ju Jung, Mi-Kyung Lee, Kyu-Shik Jeong and Myung-Sook Choi. The Hypoglycemic Effects of Hesperidin and Naringin Are Partly Mediated by Hepatic Glucose-Regulating Enzymes in C57BL/KsJ-db/db Mice. The American Society for Nutritional Sciences J. Nutr. 2004, 134: 2499-2503.
32. Yagi K. A simple fluorometric assay for lipid peroxide in blood plasma. Biochem Med. 1976, 15: 212-216.